BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38178741)

  • 1. [Interpretation of the 5th edition WHO classification of adrenal cortical tumors].
    Zhang LK; Liu ZY
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):16-21. PubMed ID: 38178741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
    Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
    Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Diagnostic Approach to Adrenocortical Tumors.
    Hodgson A; Pakbaz S; Mete O
    Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.
    Jangir H; Ahuja I; Agarwal S; Jain V; Meena JP; Agarwala S; Sharma R; Sharma MC; Iyer VK; Mani K
    Endocr Pathol; 2023 Jun; 34(2):213-223. PubMed ID: 37160532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.
    Mete O; Gucer H; Kefeli M; Asa SL
    Am J Surg Pathol; 2018 Feb; 42(2):201-213. PubMed ID: 28877067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
    Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
    Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
    Sasano H; Suzuki T; Moriya T
    Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
    Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
    Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic Features of Adrenal Cortical Carcinoma.
    Gambella A; Volante M; Papotti M
    Adv Anat Pathol; 2023 Jan; 30(1):34-46. PubMed ID: 36084635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumors of the adrenal glands : Update].
    Saeger W; Komminoth P
    Pathologe; 2019 Jul; 40(4):467-492. PubMed ID: 31250089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Oncocytic Adrenal Cortical Neoplasm with Uncertain Malignant Potential Turned Out to Be Oncocytic Adrenal Cortical Carcinoma with Distant Metastasis: Could Pathology Do Better Initially?
    Huang CP; Dai MS; Kao CC; Tsai WC; Yu CP
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current criteria for the diagnosis of adrenocortical carcinoma].
    Selivanova LS; Roslyakova AA; Kovalenko YA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
    Arkh Patol; 2019; 81(3):66-73. PubMed ID: 31317933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
    Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
    J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors.
    Papotti M; Duregon E; Volante M; McNicol AM
    Endocr Pathol; 2014 Mar; 25(1):35-48. PubMed ID: 24382573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting.
    Giordano TJ; Berney D; de Krijger RR; Erickson L; Fassnacht M; Mete O; Papathomas T; Papotti M; Sasano H; Thompson LDR; Volante M; Gill AJ
    Hum Pathol; 2021 Apr; 110():50-61. PubMed ID: 33058949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.
    de Krijger RR; Papathomas TG
    Virchows Arch; 2012 Jan; 460(1):9-18. PubMed ID: 22086150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncocytic adrenocortical carcinoma: a rare adrenal tumor subtype.
    Sumner E; Acar BC; Acker MR
    Can J Urol; 2017 Jun; 24(3):8865-8867. PubMed ID: 28646944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the 2022 WHO Classification of Parathyroid Tumors.
    Erickson LA; Mete O; Juhlin CC; Perren A; Gill AJ
    Endocr Pathol; 2022 Mar; 33(1):64-89. PubMed ID: 35175514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.